Supply of Inactivated Hepatitis A and Recombinant Hepatitis B Vaccine

The contract requires the supply of FDA-approved, commercially available inactivated Hepatitis A vaccine and recombinant Hepatitis B vaccine that meet all federal procurement standards. The vaccines must be produced and packaged in full compliance with regulatory requirements and suitable for distribution within the U.S. federal system. Delivery is specified under FOB Destination terms, meaning the supplier is responsible for all transportation costs and risks until the product reaches the designated delivery point. The contract is classified as a subcontract under NAICS code 325412, which pertains to pharmaceutical and biological product manufacturing, and is managed by the Defense Logistics Agency on behalf of the Department of Defense. The solicitation was posted on August 7, 2026, and is associated with the contract number SPE2DX25D8022 and delivery order SPE2D926F8022, indicating it is part of a larger logistical procurement framework aimed at supporting public health and readiness requirements within the federal sector.